Skip to main content


Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 11/2011

Ausgabe 11/2011

Inhaltsverzeichnis ( 12 Artikel )

01.11.2011 | Review | Ausgabe 11/2011

Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma

Adam J. Bograd, Kei Suzuki, Eva Vertes, Christos Colovos, Eduardo A. Morales, Michel Sadelain, Prasad S. Adusumilli

01.11.2011 | Opinion Paper | Ausgabe 11/2011

Dual biological effects of the cytokines interleukin-10 and interferon-γ

Cailin Moira Wilke, Shuang Wei, Lin Wang, Ilona Kryczek, John Kao, Weiping Zou

01.11.2011 | Original article | Ausgabe 11/2011

Priming with very low-affinity peptide ligands gives rise to CD8+ T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)β-mediated suppression

Jeremy A. O’Sullivan, Andrew Zloza, Frederick J. Kohlhapp, Tamson V. Moore, Andrew T. Lacek, Nickolai O. Dulin, José A. Guevara-Patiño

01.11.2011 | Original article | Ausgabe 11/2011

Vaccination of patients with cutaneous melanoma with telomerase-specific peptides

Robert E. Hunger, Kristin Kernland Lang, Carrie J. Markowski, Sissel Trachsel, Mona Møller, Jon A. Eriksen, Anne-Marie Rasmussen, Lasse R. Braathen, Gustav Gaudernack

01.11.2011 | Original article | Ausgabe 11/2011

Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide

Mitsuru Sakakibara, Tatsuya Kanto, Michiyo Hayakawa, Shoko Kuroda, Hideki Miyatake, Ichiyo Itose, Masanori Miyazaki, Naruyasu Kakita, Koyo Higashitani, Tokuhiro Matsubara, Naoki Hiramatsu, Akinori Kasahara, Tetsuo Takehara, Norio Hayashi

01.11.2011 | Original article | Ausgabe 11/2011

Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4

Dawn Holt, Xinrong Ma, Namita Kundu, Amy Fulton

01.11.2011 | Original Article | Ausgabe 11/2011

Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietin

Hui Li, Hua Zhao, Jinpu Yu, Yanjun Su, Shui Cao, Xiumei An, Xiubao Ren

01.11.2011 | Original Article | Ausgabe 11/2011

Vaccination with CD133+ melanoma induces specific Th17 and Th1 cell–mediated antitumor reactivity against parental tumor

Takao Miyabayashi, Hiroshi Kagamu, Jun Koshio, Kosuke Ichikawa, Junko Baba, Satoshi Watanabe, Hiroshi Tanaka, Junta Tanaka, Hirohisa Yoshizawa, Koh Nakata, Ichiei Narita

01.11.2011 | Original article | Ausgabe 11/2011

Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation

Edit Kovalcsik, Katie Lowe, Mike Fischer, Angus Dalgleish, Mark D. Bodman-Smith

01.11.2011 | Original article | Ausgabe 11/2011

Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™

Theo Nicholaou, Weisan Chen, Ian D. Davis, Heather M. Jackson, Nektaria Dimopoulos, Catherine Barrow, Judy Browning, Duncan MacGregor, David Williams, Wendie Hopkins, Eugene Maraskovsky, Ralph Venhaus, Linda Pan, Eric W. Hoffman, Lloyd J. Old, Jonathan Cebon

01.11.2011 | Short communication | Ausgabe 11/2011 Open Access

Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer

Riccardo Turrini, Anna Merlo, Riccardo Dolcetti, Paola Zanovello, Antonio Rosato

01.11.2011 | Meeting report | Ausgabe 11/2011

“Tumor immunology meets oncology (TIMO) VII” from 15th to 16th of April 2011 in Halle/Saale, Germany

Juergen Bukur, Elfriede Noessner, Barbara Seliger

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.